Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity

被引：31

作者：

Qu, Menghua ^{[1
]}

Liu, Zhihao ^{[1
]}

Zhao, Dan ^{[1
]}

Wang, Changyuan ^{[1
]}

Zhang, Jianbin ^{[1
]}

Tang, Zeyao ^{[1
]}

Liu, Kexin ^{[1
]}

Shu, Xiaohong ^{[1
]}

Yuan, Hong ^{[2
]}

Ma, Xiaodong ^{[1
]}

机构：

[1] Dalian Med Univ, Coll Pharm, Dalian 116044, Peoples R China

[2] Dalian Med Univ, Affiliated Hosp 1, Clin Lab, Dalian 116011, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2017年 / 25卷 / 15期

基金：

中国国家自然科学基金;

关键词：

Cancer; FAK; Inhibitor; Pyrimidine; Sulfonamide; IN-VIVO; CANCER; DISCOVERY; CELLS; ASSAY;

D O I：

10.1016/j.bmc.2017.05.044

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A class of sulfonamide-substituted diphenylpyrimidines (Sul-DPPYs) were synthesized to improve activity against the focal adhesion kinase (FAK). Most of these new Sul-DPPYs displayed moderate activity against the FAK enzyme with IC50 values of less than 100 nM; regardless, they could effectively inhibit several classes of refractory cancer cell lines with IC50 values of less than 10 mu M, including the pancreatic cancer cell lines (AsPC-1, Panc-1 and BxPC-3), the NSCLC-resistant H1975 cell line, and the B lymphocyte cell line (Ramos cells). Results of flow cytometry indicated that inhibitor 7e promoted apoptosis of pancreatic cancer cells in a dose-dependent manner. In addition, it almost completely induced the apoptosis at a concentration of 10 mu M. Compound 7e may be selected as a potent FAK inhibitor for the treatment of pancreatic cancer. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：3989 / 3996

页数：8

共 41 条

[31] Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity
El-Damasy, Ashraf K.
Jin, Heewon
Seo, Seon Hee
Bang, Eun-Kyoung
Keum, Gyochang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
[32] Design, synthesis, and biological evaluation of novel 5,7,4′-trimethoxyflavone sulfonamide-based derivatives as highly potent inhibitors of LRPPRC/STAT3/CDK1
Wu, Rui
Li, Pan
Hao, Bingbing
Fredimoses, Mangaladoss
Ge, Yunxiao
Zhou, Yubing
Tang, Lin
Li, Yuanying
Liu, Hangrui
Janson, Victor
Hu, Yamei
Liu, Hui
BIOORGANIC CHEMISTRY, 2024, 153
[33] Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity
Elkotamy, Mahmoud S.
Elgohary, Mohamed K.
Alkabbani, Mahmoud Abdelrahman
Binjubair, Faizah A.
Alanazi, Manal M.
Alsulaimany, Marwa
Al-Rashood, Sara T.
Ghabbour, Hazem A.
Abdel-Aziz, Hatem A.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025,
[34] The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents
Zhang, Xin
Raghavan, Sudhir
Ihnat, Michael
Hamel, Ernest
Zammiello, Cynthia
Bastian, Anja
Mooberry, Susan L.
Gangjee, Aleem
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2408 - 2423
[35] Design, synthesis and biological evaluation of thieno[3,2-c]pyrazol-urea derivatives as potent glycogen synthase kinase 3β inhibitors based on the DFG-out conformation
Yan, Ning
Liu, Hong-Yan
Kong, Ting-Ting
Kong, Zi-Hao
Li, Ling-Yun
Ma, Xin
Zeng, Yan-Li
Wang, Mei-Jun
Tang, Long-Qian
Zhang, Cheng-Mei
Liu, Zhao-Peng
Liu, Chao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 112
[36] Design, synthesis and biological evaluation of indolin-2-one-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase3 (FLT3)
Ma, Fei
Liu, Peng
Lei, Min
Liu, Jian
Wang, Hongtao
Zhao, Shaohua
Hu, Lihong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 72 - 86
[37] Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mahmoud, Mohamed E.
Ahmed, Eman M.
Ragab, Hamdy M.
Eltelbany, Rania Farag A.
Hassan, Rasha A.
RSC ADVANCES, 2024, 14 (41) : 30346 - 30363
[38] Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer
Cheng, Rongjie
Lv, Xiashi
Bu, Huagang
Xu, Qiaoliang
Wu, Jianzhuang
Xie, Kexin
Tang, Jiaqi
Wang, Lei
Zhuang, Jian
Zhang, Yihua
Zhang, Yaliang
Yan, Chao
Lai, Yisheng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
[39] Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer
Cheng, Rongjie
Lv, Xiashi
Bu, Huagang
Xu, Qiaoliang
Wu, Jianzhuang
Xie, Kexin
Tang, Jiaqi
Wang, Lei
Zhuang, Jian
Zhang, Yihua
Zhang, Yaliang
Yan, Chao
Lai, Yisheng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
[40] Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d] pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer
Wei, Wei
Feng, Zhanzhan
Liu, Zhihao
Li, Xinyue
He, Hualong
Ran, Kai
Shi, Yaojie
Zhu, Yongxia
Ye, Tinghong
Gao, Chao
Wang, Ningyu
Yu, Luoting
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 228

← 1 2 3 4 5 →